Cidara Therapeutics (CDTX) had the highest return in 2015 by a US stock with a market cap of $1B+, returning 2,045%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Cidara Therapeutics (CDTX) | 2015 | 2,045% |
Celsius (CELH) | 2015 | 287.94% |
Exelixis (EXEL) | 2015 | 283.67% |
Galapagos NV ADR (GLPG) | 2015 | 231.72% |
eXp World (EXPI) | 2015 | 184.83% |
Sarepta Therapeutics (SRPT) | 2015 | 164.61% |
Caesars Entertainment (CZR) | 2015 | 159.43% |
Ultragenyx (RARE) | 2015 | 152.54% |
Neurocrine Biosciences (NBIX) | 2015 | 150.42% |
Globant (GLOB) | 2015 | 142.78% |
Wayfair (W) | 2015 | 138.22% |
LeMaitre Vascular (LMAT) | 2015 | 137.18% |
Netflix (NFLX) | 2015 | 132.71% |
Collegium Pharmaceutical (COLL) | 2015 | 129.17% |
Genmab A-S (GMAB) | 2015 | 123.37% |
Iradimed (IRMD) | 2015 | 118.99% |
Amazon (AMZN) | 2015 | 116.23% |
Coca-Cola Consolidated (COKE) | 2015 | 107.08% |
Pampa Energia SA ADR (PAM) | 2015 | 104.07% |
Ligand Pharmaceuticals (LGND) | 2015 | 102.01% |
Trip Group Ltd ADR (TCOM) | 2015 | 101.44% |
National Beverage (FIZZ) | 2015 | 100.89% |
Dycom Industries (DY) | 2015 | 98.07% |
Flutter Entertainment (FLUT) | 2015 | 97.45% |
MaxLinear (MXL) | 2015 | 97.19% |
